Histamine, Plasma
Test Mnemonic
PHISTA
CPT Codes
- 83088 - QTY (1)
LOINC ®
34316-0
Performing Laboratory
ARUP
Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 1 mL | Plasma | EDTA (Lavender) | Frozen, Critical | Critical Frozen. Collect in a pre-chilled tube and on ice. Centrifuge refrigerated and separate upper two-thirds of plasma within 20 minutes and freeze immediately in a standard aliquot tube. Separate specimens must be submitted when multiple tests are ordered. |
Alternate Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 1 mL | Plasma | See note | Frozen, Critical | Lavender EDTA gel collection tube: Collect in a pre-chilled tube and on ice. Aliquot plasma immediately after centrifugation and freeze separately in a standard aliquot tube. Separate specimens must be submitted when multiple tests are ordered. |
Minimum Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 0.5 mL |
Stability
| Environmental Condition | Description |
|---|---|
| Frozen | After separation from cells: 6 months |
| Refrigerated | After separation from cells: 6 hours |
| Ambient | After separation from cells: Unacceptable |
Days Performed
Tue, Sat
Turnaround Time
2 - 7 days
Methodology
| Name | Description |
|---|---|
| Enzyme-Linked Immunosorbent Assay (ELISA) |
Reference Range
| Histamine, Plasma | |||||
|---|---|---|---|---|---|
| Sex | Age From | Age To | Type | Range | Range Unit |
| Years | 99 Years | Normal | 0 - 8 | nmol/L |
Special Info
Critical Frozen. Separate specimens must be submitted when multiple tests are ordered. Unacceptable conditions: Lipemic or hemolyzed specimens. This test is New York DOH approved.
Clinical Info
Aid in evaluation of patient with allergic signs and symptoms (e.g., anaphylaxis). May assist in the diagnosis and monitoring of mast-cell activation disorders.